A Review of the Pharmaceutical Industry and the Development of a Regional Sales Forecasting Model for Dupont Merck Pharma Canada PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download A Review of the Pharmaceutical Industry and the Development of a Regional Sales Forecasting Model for Dupont Merck Pharma Canada PDF full book. Access full book title A Review of the Pharmaceutical Industry and the Development of a Regional Sales Forecasting Model for Dupont Merck Pharma Canada by Chantale Fortin. Download full books in PDF and EPUB format.
Author: Chantale Fortin
Publisher:
ISBN:
Category : Pharmaceutical industry
Languages : en
Pages : 112
Get Book Here
Book Description
Author: Chantale Fortin
Publisher:
ISBN:
Category : Pharmaceutical industry
Languages : en
Pages : 112
Get Book Here
Book Description
Author: Nawaz Ahmad
Publisher:
ISBN:
Category :
Languages : en
Pages : 7
Get Book Here
Book Description
This study aims to develop a stochastic framework of model to forecast future sales for pharmaceutical industry. In this regard, the study focuses on Merck Pharmaceutical monthly sales data. This study examines the Sale forecasting models. The study includes monthly data published in the annual reports of the company from Jan. 2008 to Dec. 2012. The time series diagram shows unequal means over the time period that suggests the data is stationary. Having transformed the data, ARMA (1, 1) model is applied which shows that there will be increase in sales by $6.784m given that in the last month sales were $1bn. On the contrary, last month's residual has an adverse effect on current month sales up to the extent of $432.942m. In this study AR (1) and MA (1) both the processes are significant at 1%.
Author: Arthur G. Cook
Publisher: Routledge
ISBN: 1351158147
Category : Business & Economics
Languages : en
Pages : 179
Get Book Here
Book Description
In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex 'black box' equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion. Art Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge. Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making.
Author: N. Lalitha
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 44
Get Book Here
Book Description
Author: Fran Hawthorne
Publisher: John Wiley & Sons
ISBN: 0471432105
Category : Business & Economics
Languages : en
Pages : 306
Get Book Here
Book Description
An in-depth look at big pharma's flagship company The Merck Druggernaut takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business. Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crain's New York Business. She has been covering business for more than twenty years for such publications as Fortune, BusinessWeek, and Institutional Investor, with a prevailing interest in healthcare and pharmaceuticals. At Crain's, she spearheads the publication of two to three special healthcare issues per year.
Author: Andre Jungmittag
Publisher: Springer Science & Business Media
ISBN: 3662041529
Category : Science
Languages : en
Pages : 195
Get Book Here
Book Description
The internationalization of research and technology is one key component of the globalization of trade and business, with potentially major impacts on patterns of economic development and public policies worldwide. Although certain aspects of this internationalization trend are well documented, and some effects can be quantified, the overall processes are extremely complex and the outcomes are highly uncertain. The existence of the phenomenon is generally accepted, but its importance and the trends are currently the topic of a lively debate. This study on "New Ways in Drug Development in Pharmaceuticals" is part of a three year project which aims at investigating how new concepts of industrial knowledge creation are implemented in the different environ ments of the innovation systems of the United States and Germany. The main focus of the overall project is a series of case studies of innovation practice in different national and sectoral contexts. The following sectors and technological fields are investigated: pharmaceuticals and new ways in drug development by the Fraunhofer Institute for Systems and Innovation Research (ISI), advanced materials by the University Hohenheim, Insti tute of International Management and Innovation (Alexander Gerybadze), financial services and home banking by the Massachusetts Institute of Tech nology (MIT), Center for Industrial Performance (Richard Lester) and the Sloan School of Management (Edward Roberts). Financially the project was supported by the German-American Academic Council, the German Federal Minstry of Education, Science Research and Technology and the Fraunhofer Society.
Author: Min Ding
Publisher: Springer Science & Business Media
ISBN: 1461478014
Category : Medical
Languages : en
Pages : 763
Get Book Here
Book Description
The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike.
Author: Malena Johannes
Publisher: ibidem-Verlag / ibidem Press
ISBN: 383826942X
Category : Medical
Languages : en
Pages : 112
Get Book Here
Book Description
Raising costs, ever-increasing regulatory hurdles, and mounting difficulties in finding the next blockbuster drug are just a few of the challenges Big Pharma currently has to face for its research and development process, the heart of its risky business. Big Data claims to be full of insights that Big Pharma need to find a way of harvesting, which could lead to new compounds. Academics, Big Data start-ups, and pharmaceutical companies have focused their research efforts on analytic tools and data technologies to store, collect, analyse, and extract these insights from massive data sets. However, the key question is whether the Big Data hype really does have the claimed accelerating effect on the complex research and development process or if it actually creates another hurdle for Big Pharma innovation. Malena Johannes' timely book sheds light on this question by examining the top 5 pharmaceutical companies and provides an overview on the status quo of Big Data applications within the pharmaceutical industry.
Author: Meir Statman
Publisher: A E I Press
ISBN:
Category : Business & Economics
Languages : en
Pages : 106
Get Book Here
Book Description
Author: Clement Bezold
Publisher: John Wiley & Sons
ISBN:
Category : Business & Economics
Languages : en
Pages : 168
Get Book Here
Book Description
